Why the study?
Bright-blood LGE imaging provides poor scar-to-blood contrast, making papillary muscle infarction visualization challenging, whereas black-blood LGE imaging overcomes this limitation by improving contrast.
Does the SPOT MRI sequence improve the detection of papillary muscle infarction compared to the PSIR sequence in patients with ischemic heart disease?
Does the SPOT MRI sequence improve the detection of papillary muscle infarction compared to the PSIR sequence in patients with ischemic heart disease?
The SPOT MRI sequence significantly improves the visual detection and enables automated assessment of papillary muscle infarction compared to standard PSIR imaging.
SPOT LGE may improve PMI detection sensitivity and automation in ischemic patients; leaves open whether visualization gains affect prognosis or management.
BACKGROUND: Papillary muscle infarction (PMI) has been linked to significantly increased mortality and is associated with ventricular arrhythmias and mitral regurgitation. Reference bright-blood late gadolinium enhancement (LGE) imaging provides poor scar-to-blood contrast, making PMI visualization challenging. Black-blood LGE imaging overcomes this limitation by improving the blood-scar contrast. PURPOSE: To evaluate a recent co-registered bright- (papillary muscle localization) and black-blood (PMI visualization) sequence (Scar-specific imaging with Preserved myOcardial visualizaTion: SPOT) to improve PMI visualization compared to a reference standard phase-sensitive inversion recovery (PSIR) sequence, and to enable automated PMI detection (auto-PMI). STUDY TYPE: Retrospective. POPULATION: 198 patients with ischemic heart disease were divided into an optimization dataset (N = 127) and a testing dataset (N = 71). FIELD STRENGTH/SEQUENCE: 2D SPOT and PSIR balanced steady-state free precession sequences at 1.5 T. ASSESSMENT: Auto-PMI included: image acquisition, slice selection, endocardial segmentation, blood pool preprocessing, and PMI detection. Three radiologists (8, 5 and 2 years of MRI experience) assessed PMI in SPOT and PSIR images independently. A consensus reading regarding all assessments of both sequences was established. The number of patients with PMI in SPOT and PSIR acquisitions was compared. The diagnostic performances of visual (SPOT and PSIR) and auto-PMI (SPOT) detection were evaluated. Inter- and intra-observer reproducibility of the visual PMI detection was assessed. STATISTICAL TESTS: McNemar test, p-value < 0.05 was considered statistically significant. RESULTS: In the testing dataset, significantly more patients with PMI were detected using SPOT compared to PSIR in each session (37 vs. 27, 36 vs. 29, 41 vs. 31, 42 vs. 25). Sensitivity ranges for visual PMI detection were significantly higher using SPOT (89%-100% vs. 61%-82%). SPOT vs. PSIR inter- and intra-observer reproducibility ranges were 77%-80% vs. 71%-77%, and 97% vs. 88%, respectively. Auto-PMI sensitivity was 87%. DATA CONCLUSION: Co-registered bright- and black-blood SPOT imaging improved visual PMI detection and facilitated automated PMI assessment. EVIDENCE LEVEL: 3. Technical Efficacy: Stage 2.
No takes yet. Share an insight, caveat, or question.
Richard et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: